Samuel Sances

Samuel Sances currently serves as the Director of Neuroscience at insitro, leading the partnership with BMS for the discovery of therapeutics for ALS. This role involves the application of machine learning to human biological data and the development of industrial in vitro human disease models, as well as small molecule and oligo therapeutics. Prior to insitro, Samuel held several positions at Cedars-Sinai, culminating in the award of a $7 million NIH grant to create advanced human Tissue Chip models for ALS, Parkinson's disease, and opiate addiction. Samuel's earlier experience includes a postdoctoral scientist role and a doctoral student position at the Sanford-Burnham Medical Research Institute, where work was conducted under Dr. E Webb. Samuel Sances holds a Ph.D. in Biomedical Science and Translational Medicine from Cedars-Sinai and a B.S. in Chemistry and Biochemistry from San Diego State University.